News & Press Releases English
Scandinavian ChemoTech AB (publ) Interim report Q1 January – March 2020 Executive Summary of the first quarter
Scandinavian ChemoTech signs its first European distribution agreement with Lee Imaging Ukraine LLC
Scandinavian ChemoTech updates its forecasts as a result of COVID-19's impact on the organisation
Chemotech Videos
Share Day in Gothenburg, November 4 2019
Share Day in Malmö on May 22, 2018
Share analysis ChemoTech Q2 2018
Our foundation
Our profound knowledge in Electroporation forms the starting point for the company’s existing product and R&D projects : IQwave™ specially desinged for both Dynamic-ElectroEnhanced Chemotherapy and the first generation Electrochemotherpy for the treatment of a range of different types of tumors.
Our research focus
Our aim is to document the effects of elctrochemotherapy for pain management for cancer patients, an area with significant unmet medical need.